HUTCHMED Historical Income Statement
| HCM Stock | USD 17.91 0.17 0.94% |
Historical analysis of HUTCHMED DRC income statement accounts such as Selling And Marketing Expenses of 31.2 M or Total Revenue of 879.9 M can show how well HUTCHMED DRC performed in making a profits. Evaluating HUTCHMED DRC income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of HUTCHMED DRC's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining HUTCHMED DRC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether HUTCHMED DRC is a good buy for the upcoming year.
HUTCHMED |
About HUTCHMED Income Statement Analysis
HUTCHMED DRC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to HUTCHMED DRC shareholders. The income statement also shows HUTCHMED investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
HUTCHMED DRC Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts HUTCHMED DRC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of HUTCHMED DRC. It is also known as HUTCHMED DRC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from HUTCHMED DRC's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into HUTCHMED DRC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.At this time, HUTCHMED DRC's Research Development is very stable compared to the past year. As of the 12th of June 2024, EBITDA is likely to grow to about 26.8 M, while Selling And Marketing Expenses is likely to drop about 31.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 592K | 652K | 759K | 879.4K | Depreciation And Amortization | 7.2M | 8.7M | 8.2M | 4.9M |
HUTCHMED DRC income statement Correlations
Click cells to compare fundamentals
HUTCHMED DRC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
HUTCHMED DRC income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 9.9M | 6.1M | 7.2M | 8.7M | 8.2M | 4.9M | |
| Interest Expense | 1.0M | 787K | 592K | 652K | 759K | 879.4K | |
| Selling And Marketing Expenses | 13.7M | 11.3M | 37.8M | 43.9M | 53.4M | 31.2M | |
| Total Revenue | 204.9M | 228.0M | 356.1M | 426.4M | 838.0M | 879.9M | |
| Gross Profit | 44.7M | 39.5M | 97.9M | 115.3M | 453.6M | 476.2M | |
| Other Operating Expenses | 349.9M | 424.6M | 684.4M | 834.1M | 820.7M | 861.7M | |
| Operating Income | (145.0M) | (188.9M) | (336.5M) | (409.8M) | 17.3M | 18.2M | |
| Ebit | (145.0M) | (188.9M) | (336.5M) | (409.8M) | 17.3M | 18.2M | |
| Research Development | 91.9M | 111.2M | 207.4M | 267.6M | 303.1M | 318.2M | |
| Ebitda | (135.1M) | (182.9M) | (329.3M) | (401.1M) | 25.5M | 26.8M | |
| Cost Of Revenue | 160.2M | 188.5M | 258.2M | 311.1M | 384.4M | 403.7M | |
| Total Operating Expenses | 189.8M | 236.1M | 426.2M | 523.0M | 436.2M | 458.0M | |
| Income Before Tax | (141.1M) | (189.7M) | (215.7M) | (410.4M) | 58.3M | 61.2M | |
| Total Other Income Expense Net | 3.9M | (787K) | 120.7M | (652K) | 41.0M | 43.0M | |
| Net Income | (144.4M) | (194.6M) | (227.7M) | (410.1M) | 100.8M | 105.8M | |
| Income Tax Expense | 3.3M | 4.8M | 11.9M | (283K) | 4.5M | 3.1M | |
| Selling General Administrative | 39.2M | 50.0M | 89.3M | 92.2M | 79.8M | 48.2M | |
| Net Income From Continuing Ops | (103.7M) | (115.5M) | (167.0M) | (360.4M) | 101.1M | 106.1M | |
| Net Income Applicable To Common Shares | (106.0M) | (125.7M) | (194.6M) | (360.8M) | (324.8M) | (308.5M) | |
| Minority Interest | 24.9M | 34.8M | (27.6M) | (449K) | (314K) | (298.3K) | |
| Tax Provision | 3.3M | 4.8M | 11.9M | (283K) | 4.5M | 4.5M | |
| Interest Income | 4.9M | 3.2M | 2.1M | 9.6M | 36.1M | 38.0M | |
| Net Interest Income | 3.9M | 2.4M | 1.5M | 8.9M | 35.4M | 37.2M | |
| Reconciled Depreciation | 4.9M | 6.1M | 7.2M | 8.7M | 8.2M | 6.5M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as HUTCHMED DRC using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in HUTCHMED Stock
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.6 | Revenue Per Share 4.93 | Quarterly Revenue Growth 0.36 | Return On Assets 0.01 | Return On Equity 0.1465 |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.